세계의 유효성분 시장 : 의약품, 농약, 퍼스널케어 및 화장품, 지역별(2024-2031년)

Active Ingredients Market Valuation - 2024-2031

The rising demand for active ingredients is largely due to increased customer knowledge and preference for health and wellness goods. Active ingredients which are critical components of medications, cosmetics, personal care products, and other health-related items play an important role in achieving the desired therapeutic or cosmetic outcome. As individuals grow more health-conscious, there is a greater demand for products that provide specialized benefits such as anti-aging, skin brightening, immune boosters, and other targeted impacts by enabling the market to surpass a revenue of USD 2.83 Billion valued in 2024 and reach a valuation of around USD 4.15 Billion by 2031.

The active ingredients market is expanding due to technological and scientific breakthroughs. Biotechnology, nanotechnology, and synthetic biology advancements have made it possible to create more potent and effective active substances. For example, using nanotechnology in skincare improves the absorption of active compounds, increasing their potency. Furthermore, the pharmaceutical business is always researching and developing novel active ingredients to meet unmet medical requirements such as therapies for chronic diseases, cancer, and mental health issues. This enables the market to grow at aCAGR of 4.90% from 2024 to 2031.

Active Ingredients Market: Definition/ Overview

Active ingredients are the key components of a product that allow it to work properly. In the case of pharmaceuticals, the active ingredient is a chemical component that directly treats or manages the symptoms of a disease or condition. For example, the active component in ibuprofen, a pain reliever is responsible for lowering pain and inflammation. Active chemicals distinguish one product from another and determine how it functions.

Active ingredients are substances in products that create the desired results whether in medications, cosmetics, or agricultural products. In medicines, active ingredients are the primary components that provide therapeutic advantages. For example, in pain relievers, the active ingredient may be ibuprofen which decreases inflammation and pain. These chemicals are carefully chosen to address specific symptoms or illnesses assuring the medication's efficacy.

The future usage of active compounds, notably in pharmaceuticals, cosmetics, and agriculture, is likely to be revolutionary as breakthroughs arise. Active ingredients are the primary components of medications that provide therapeutic effects. With advances in biotechnology and customized medicine, the future will most certainly see a trend toward more tailored active ingredients that cater to specific genetic profiles. This means that therapies may become more successful and have fewer negative effects if they are tailored to each individual's biological composition.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Extensive Use in Drug Manufacturing Drive the Active Ingredients Market?

The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018, accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and, by extension, active ingredients.

The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry. The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018 accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and by extension, active ingredients. The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry.

Will the Regulatory Constraints Hamper the Active Ingredients Market?

Regulatory limits present important obstacles for the active ingredients market, potentially impeding its growth and development. The demanding clearance process for new active ingredients, notably in the pharmaceutical and agrochemical industries is a significant regulatory barrier. According to the United States Food and Drug Administration (FDA), the average time for approving a new drug application is about 12 months with some complex applications taking considerably longer. This prolonged timeline may delay market introduction for innovative items and increase the company's development expenses.

Furthermore, the European Medicines Agency (EMA) reports that the average period for evaluating a new active substance is approximately 423 days highlighting the time-consuming nature of regulatory compliance in key markets. Another key regulatory restraint is an increased emphasis on environmental and safety regulations. The European Chemicals Agency (ECHA) enforces the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) law which requires enterprises to register chemical substances produced or imported in quantities of one tonne or more each year. Furthermore, the United States Environmental Protection Agency (EPA) reported completing over 22,000 pesticide product reviews in fiscal year 2020 indicating substantial regulatory monitoring in the agrochemical industry.

Category-Wise Acumens

Will a Wide Range of Serious and Chronic Medical Conditions Drive Growth in the Pharmaceutical Segment?

Prescription medications dominate because of their importance in treating a wide spectrum of serious and chronic medical disorders. Prescription medications contain active chemicals that have been precisely designed and approved for targeted therapies which are frequently used to treat complicated conditions such as cancer, cardiovascular difficulties, and autoimmune disorders. These active chemicals go through extensive research and clinical trials to confirm their efficacy and safety making them indispensable in modern medicine. The increased frequency of chronic diseases, an aging population, and ongoing innovation in medication development all contribute to prescription pharmaceutical supremacy.

Pharmaceutical companies invest extensively in research and development to generate new active components that can deliver more effective treatments with fewer side effects highlighting the importance of prescription pharmaceuticals. OTC medications and biological products play important roles in the market but they do not supplant prescription drugs. OTC medications while necessary for treating common and less severe illnesses, often contain well-established active components and do not require doctor supervision resulting in lower regulatory obstacles and research expenditure when compared to prescription drugs.

Will the Growing Consumer Awareness Drive the Personal Care and Cosmetics Segment?

Skincare goods segment is projected to dominate the market over the forecast period. This dominance is driven by increasing consumer awareness and concern about skin health, aging, and general skin look. Moisturizers, anti-aging creams, and treatments for acne and hyperpigmentation are becoming increasingly popular as customers prioritize preserving a young appearance and addressing specific skin ailments. The global increase in pollution, stress, and UV radiation has increased the demand for effective skincare solutions resulting in a spike in the discovery and application of new active ingredients.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers changing wants.

Country/Region-wise Acumens

Will the Rising Prevalence of Preventable Chronic Diseases Drive the Market in the North American Region?

The growing frequency of avoidable chronic diseases in North America is primarily driving the market for active ingredients. This tendency is especially noticeable in the United States which accounts for a sizable chunk of the industry. The increasing frequency of chronic diseases in North America is a significant driver of the active ingredients market. According to the Centers for Disease Control and Prevention (CDC), six out of ten persons in the United States have a chronic disease with four out of ten having two or more chronic disorders. These astonishing figures underline the critical need for improved treatments and prevention strategies.

Chronic diseases impose an equal economic impact with the National Center for Chronic Disease Prevention and Health Promotion claiming that people with chronic and mental health conditions account for 90% of the nation's $3.8 trillion in yearly health care costs. This significant economic impact highlights the significance of treating chronic diseases and increases demand for active ingredients in medicines and nutraceuticals. The active ingredients market is also being boosted by the increased awareness of preventive healthcare measures among North Americans. The Healthy People 2030 effort launched by the United States Department of Health and Human Services seeks to reduce the burden of preventable diseases by encouraging health and wellness.

Will the Rapid Urbanization and an Expanding Middle-Class Population Drive the Market in the Asia Pacific Region?

The Asia Pacific region is witnessing the world's fastest urbanization rate with China and India leading the way. This fast urbanization combined with a rapidly rising middle-class population is expected to be a big driver of the region's active ingredients market. Urbanization in Asia Pacific is accelerating at an unprecedented rate. According to the United Nations Department of Economic and Social Affairs, Asia's urban population is expected to grow from 2.2 billion in 2020 to 3.5 billion in 2050. China alone is estimated to add 255 million urban residents between 2020 and 2050. This tremendous change to urban living is accompanied by changing lifestyles, higher disposable incomes, and heightened knowledge of personal care and health products.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers' changing wants. Additionally, the rise of personalized skincare in which products are tailored to individual skin types and conditions has led to greater use of specific active ingredients that address unique concerns, further driving the market growth.

Competitive Landscape

The Active Ingredients Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the active ingredients market include:

BASF SE

The Dow Chemicals Company

Ashland, Inc.

Rhodia

Du Pont

Sumitomo Group

LOral S.A.

Beiersdorf AG

Sederma, Inc.

Evonik Industries

Latest Developments

In October 2020, Evonik significantly increased its bio-based line of active ingredients for the beauty and personal care industries in response to rising demand for innovative, sustainably sourced products.

In April 2021, Ashland announced a new active skin care component, claiming to enhance vibrancy and "glow" for a well-aged appearance.

TABLE OF CONTENTS

1.Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Active Ingredients Market, By Pharmaceuticals

• Prescription Drugs
• Over-the-Counter (OTC) Drugs
• Biological Products

5 Active Ingredients Market, By Agrochemicals

• Herbicides
• Insecticides
• Fungicides
• Plant Growth Regulators

6 Active Ingredients Market, By Personal Care and Cosmetics

• Skin Care Products
• Hair Care Products
• Cosmetics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pfizer
• Merck & Co.
• Roche
• Novartis
• Johnson & Johnson
• BASF SE
• Dow Chemical Company
• Evonik Industries
• Ashland Inc.
• Clariant

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References